These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26088287)

  • 1. Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus.
    Berger AR; Cruess AF; Altomare F; Chaudhary V; Colleaux K; Greve M; Kherani A; Mandelcorn ED; Parsons H; Rhéaume MA; Tourville E
    Ophthalmologica; 2015; 234(1):6-25. PubMed ID: 26088287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration.
    Cruess AF; Berger A; Colleaux K; Greve M; Harvey P; Kertes PJ; Sheidow T; Tourville E; Williams G; Wong D
    Can J Ophthalmol; 2012 Jun; 47(3):227-35. PubMed ID: 22687297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion.
    Tan MH; McAllister IL; Gillies ME; Verma N; Banerjee G; Smithies LA; Wong WL; Wong TY
    Am J Ophthalmol; 2014 Jan; 157(1):237-247.e1. PubMed ID: 24112635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal vein thrombosis: pathogenesis and management.
    Rehak M; Wiedemann P
    J Thromb Haemost; 2010 Sep; 8(9):1886-94. PubMed ID: 20492457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
    Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
    JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion.
    Khayat M; Williams M; Lois N
    Surv Ophthalmol; 2018; 63(6):816-850. PubMed ID: 29705175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial.
    Pielen A; Mirshahi A; Feltgen N; Lorenz K; Korb C; Junker B; Schaefer C; Zwiener I; Hattenbach LO;
    Acta Ophthalmol; 2015 Feb; 93(1):e29-37. PubMed ID: 25042729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
    Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
    Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
    Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
    Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of macular edema secondary to retinal vein occlusion].
    Girmens JF; Glacet-Bernard A; Kodjikian L; Nghiêm-Buffet S; Massé H; Fourmaux E; Wolff B; Roquet W; Gaucher D; Baillif S; Tadayoni R
    J Fr Ophtalmol; 2015 Mar; 38(3):253-63. PubMed ID: 25683131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
    Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
    Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for branch retinal vein occlusion: an evidence-based systematic review.
    McIntosh RL; Mohamed Q; Saw SM; Wong TY
    Ophthalmology; 2007 May; 114(5):835-54. PubMed ID: 17397923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practice in the management of branch retinal vein occlusion in Japan: Survey results of retina specialists in Japan.
    Ogura Y; Kondo M; Kadonosono K; Shimura M; Kamei M; Tsujikawa A
    Jpn J Ophthalmol; 2019 Sep; 63(5):365-373. PubMed ID: 31428900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravitreal anti-vascular endothelial growth factor treatment on retinal vasculature in retinal vein occlusion as determined by ultra wide-field fluorescein angiography.
    Vance SK; Chang LK; Imamura Y; Freund KB
    Retin Cases Brief Rep; 2011; 5(4):343-7. PubMed ID: 25390431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branch retinal vein occlusion: classification and treatment.
    Parodi MB; Bandello F
    Ophthalmologica; 2009; 223(5):298-305. PubMed ID: 19372724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal vein occlusion: current treatment.
    Lattanzio R; Torres Gimeno A; Battaglia Parodi M; Bandello F
    Ophthalmologica; 2011; 225(3):135-43. PubMed ID: 20938213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study.
    Boyer D; Heier J; Brown DM; Clark WL; Vitti R; Berliner AJ; Groetzbach G; Zeitz O; Sandbrink R; Zhu X; Beckmann K; Haller JA
    Ophthalmology; 2012 May; 119(5):1024-32. PubMed ID: 22440275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year.
    Kriechbaum K; Prager F; Geitzenauer W; Benesch T; Schütze C; Simader C; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2415-21. PubMed ID: 19744723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.